Clinical studies recruiting near Majadahonda

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA ( Site 1 · Merck Sharp & Dohme LLC · NCT06136559 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA-Medical · Merck Sharp & Dohme LLC · NCT06393374 Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Phase N/A · Hospital Universitario Puerta de Hierro · Spanish Oncology Genito-Urinary Group · NCT06724159 Spanish Series of Patients Treated With the Radionuclide Lutetium177
Phase N/A · Hospital Univeritario Puerta de Hierro · Sociedad Española de Medicina Nuclear e Imagen Molecular · NCT04949282 A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut
Phase 2/Phase 3 · Hospital Universitario Puerta de Hierro - Majadahonda /ID# 2 · AbbVie · NCT06109272 A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · Hospital Universitario Puerta de Hierro - Majadahonda · Hoffmann-La Roche · NCT04929223 Visugromab in Cachexia International Trial
Phase 2/Phase 3 · Hospital Universitario Puerta de Hierro · CatalYm GmbH · NCT07112196 Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
Phase 2 · Hospital Universitario Puerta de Hierro · Fundación GECP · NCT05398094 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Hospital Universitario Puerta de Hierro Majadahonda · Loxo Oncology, Inc. · NCT05254743 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA-Medical · Merck Sharp & Dohme LLC · NCT06077760 Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phase N/A · Research Site · AstraZeneca · NCT06465810 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Hospital Universitario Puerta de Hierro Majadahonda · Amgen · NCT07005128 Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
Phase 3 · Hospital Universitario Puerta De Hierro · European Organisation for Research and Treatment of Cancer - · NCT05974774 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · Hospital Universitario Puerta de Hierro Majadahonda · Bristol-Myers Squibb · NCT05489705 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (
Phase 3 · Investigational Site Number : 7240006 · Sanofi · NCT06290128 Post-Market Clinical Follow Up Study With Navitor Valve
Phase N/A · Hospital Universitario Puerta de Hierro · Abbott Medical Devices · NCT06008080 Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously
Phase 3 · Hospital Universitario Puerta de Hierro · Fundación GECP · NCT06431633 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0287 · Bristol-Myers Squibb · NCT03899155 Usefulness of PET-CT for Invasive Fungal Infection
Phase N/A · Hospital Universitario Puerta de Hierro · Puerta de Hierro University Hospital · NCT05688592 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-38006, Majadahonda, Madrid · Colorado Prevention Center · NCT06033950 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Phase N/A · Hospital Universitario Puerta de Hierro · Abbott Medical Devices · NCT03876054 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · Hospital Universitario Puerta de Hierro de Majadahonda · Ipsen · NCT06016842 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Hospital Universitario Puerta de Hierro Majadahonda · Bristol-Myers Squibb · NCT06561386 Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Phase 4 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05803941 A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Phase 3 · Hospital Universitario Puerta de Hierro Majadahonda · Dimerix Bioscience Pty Ltd · NCT05183646 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre D
Phase N/A · Hospital Universitario Puerta De Hierro · Fundación EPIC · NCT06620757 A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure
Phase 2 · Hospital Universitario Puerta de Hierro Majadahonda · Novo Nordisk A/S · NCT06979375

Look up another city

Look up another condition